title: [Midline malignant granuloma and cyclophosphamide].
abstract: One case is presented whose characteristics features were breast hypertrophy, normal immune functions and the efficacy of cyclophosphamide alone : A complete remission is present 31 months after the granuloma started, after 7 and a half months of treatment by cyclophosphamide, 14 months after its interruption by the patient. It is proposed that lethal midline granuloma is a localised form of Wegener's granulomatosis ; between these extreme forms are the limited (pulomonary) form of Wegener's granulomatosis, and the lethal midline granuloma with cutaneous, glandular, digestive or urethrogenital involvements. Therapeutic is briefly reviewed and the efficacy of cyclophosphamide claimed.
mesh_terms: D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006103:Granuloma, Lethal Midline / Q000188:drug therapy* / Q000209:etiology / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D003520:Cyclophosphamide
vernacular_title: Granulome malin centrofacial et cyclophosphamide